These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12820174)

  • 1. Citalopram treatment of social anxiety disorder with comorbid major depression.
    Schneier FR; Blanco C; Campeas R; Lewis-Fernandez R; Lin SH; Marshall R; Schmidt AB; Sanchez-Lacay JA; Simpson HB; Liebowitz MR
    Depress Anxiety; 2003; 17(4):191-6. PubMed ID: 12820174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.
    Mohamed S; Osatuke K; Aslam M; Kasckow J
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):201-9. PubMed ID: 17062320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label trial of citalopram for major depression in patients with hepatitis C.
    Gleason OC; Yates WR; Isbell MD; Philipsen MA
    J Clin Psychiatry; 2002 Mar; 63(3):194-8. PubMed ID: 11926717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia.
    Bouwer C; Stein DJ
    J Affect Disord; 1998 Apr; 49(1):79-82. PubMed ID: 9574863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do atypical features affect outcome in depressed outpatients treated with citalopram?
    Stewart JW; McGrath PJ; Fava M; Wisniewski SR; Zisook S; Cook I; Nierenberg AA; Trivedi MH; Balasubramani GK; Warden D; Lesser I; John Rush A
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):15-30. PubMed ID: 19341509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, randomized comparison of memantine and escitalopram for the treatment of major depressive disorder comorbid with alcohol dependence.
    Muhonen LH; Lönnqvist J; Juva K; Alho H
    J Clin Psychiatry; 2008 Mar; 69(3):392-9. PubMed ID: 18348597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
    Trivedi MH; Rush AJ; Wisniewski SR; Nierenberg AA; Warden D; Ritz L; Norquist G; Howland RH; Lebowitz B; McGrath PJ; Shores-Wilson K; Biggs MM; Balasubramani GK; Fava M;
    Am J Psychiatry; 2006 Jan; 163(1):28-40. PubMed ID: 16390886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escitalopram : a review of its use in the management of major depressive and anxiety disorders.
    Waugh J; Goa KL
    CNS Drugs; 2003; 17(5):343-62. PubMed ID: 12665392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citalopram treatment of paroxetine-intolerant depressed patients.
    Thase ME; Ferguson JM; Lydiard RB; Wilcox CS
    Depress Anxiety; 2002; 16(3):128-33. PubMed ID: 12415538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].
    Azorin JM; Llorca PM; Despiegel N; Verpillat P
    Encephale; 2004; 30(2):158-66. PubMed ID: 15107719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing effects of citalopram with fluoxetine on sleep quality in patients with major depressive disorder.
    Shahsavand-Ananloo E; Berenji F; Sadeghniiat K; Alimadadi A; Zahiroddin AR; Tabatabaee M; Abbasi-Asl M; Ghaeli P
    Eur Rev Med Pharmacol Sci; 2013 May; 17(9):1155-61. PubMed ID: 23690183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.
    Montgomery SA; Nil R; Dürr-Pal N; Loft H; Boulenger JP
    J Clin Psychiatry; 2005 Oct; 66(10):1270-8. PubMed ID: 16259540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open-label treatment with escitalopram in patients with social anxiety disorder and fear of blushing.
    Pelissolo A; Moukheiber A
    J Clin Psychopharmacol; 2013 Oct; 33(5):695-8. PubMed ID: 23948787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of generalized anxiety disorder with citalopram.
    Varia I; Rauscher F
    Int Clin Psychopharmacol; 2002 May; 17(3):103-7. PubMed ID: 11981350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escitalopram maintenance treatment for prevention of recurrent depression: a randomized, placebo-controlled trial.
    Kornstein SG; Bose A; Li D; Saikali KG; Gandhi C
    J Clin Psychiatry; 2006 Nov; 67(11):1767-75. PubMed ID: 17196058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram for social phobia: a clinical case series.
    Simon NM; Sharma SG; Worthington JJ; Marzol PC; Pollack MH
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Oct; 25(7):1469-74. PubMed ID: 11513360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-reported outcomes of quality of life, functioning, and depressive symptom severity in major depressive disorder comorbid with panic disorder before and after SSRI treatment in the star*d trial.
    IsHak WW; Mirocha J; Christensen S; Wu F; Kwock R; Behjat J; Pi S; Akopyan A; Peselow ED; Cohen RM; Elashoff D
    Depress Anxiety; 2014 Aug; 31(8):707-16. PubMed ID: 23861180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.